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The study of single cells has evolved over the past several years to include expression 
and genomic analysis of an increasing number of single cells. Several studies have 
demonstrated wide spread variation and heterogeneity within cell populations of similar 
phenotype. While the characterization of these populations will likely set the foundation 
for our understanding of genomic- and expression-based diversity, it will not be able 
to link the functional differences of a single cell to its underlying genomic structure and 
activity. Currently, it is difficult to perturb single cells in a controlled environment, monitor 
and measure the response due to perturbation, and link these response measurements 
to downstream genomic and transcriptomic analysis. In order to address this challenge, 
we developed a platform to integrate and miniaturize many of the experimental steps 
required to study single-cell function. The heart of this platform is an elastomer-based 
integrated fluidic circuit that uses fluidic logic to select and sequester specific single 
cells based on a phenotypic trait for downstream experimentation. Experiments with 
sequestered cells that have been performed include on-chip culture, exposure to various 
stimulants, and post-exposure image-based response analysis, followed by preparation 
of the mRNA transcriptome for massively parallel sequencing analysis. The flexible sys-
tem embodies experimental design and execution that enable routine functional studies 
of single cells.
Keywords: single-cell, mRnA-seq, functional studies, Fluidigm, polaris
InTRoDUcTIon
Recent single-cell transcriptomic analyses have documented the importance of cellular heterogene-
ity in studying cancer (Ennen et al., 2014; Saadatpour et al., 2014; Kim et al., 2015), immunology 
(Shalek et al., 2014), developmental biology (Briggs et al., 2015), stem cell research (Wilson et al., 
2015), and neurobiology (Pollen et al., 2015). It has been estimated that the human body contains 
37.2 trillion cells (Bianconi et al., 2013), excluding the complex microbiome that lives in the human 
body. High-throughput single-cell mRNA sequencing provides an unbiased path to classifying this 
FIgURe 1 | Typical workflow for single-cell functional studies. The input single-cell suspension can be obtained from blood, primary cells, or cell culture. In 
the case of rare cells or a subset of cell population, there is an option to enrich them prior to use with Polaris using either fluorescence-assisted cell sorting (FACS) or 
other methods. Subsequently, the cells are labeled with a universal fluorescent marker for tracking the cells on the Fluidigm® Polaris system. Most of the single-cell 
functional study steps are automated on the Polaris system. The Polaris system generates preamplified full-length cDNA, which can be further processed for library 
preparation and massive parallel sequencing for mRNA sequencing.
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vast number of cells into cell types. This endeavor has stimulated 
the development of methods to increase throughput (Fan et al., 
2015; Klein et al., 2015; Macosko et al., 2015). The classification 
of cell types can be thought of as a high-resolution anatomy. At 
the single-cell level, moving from anatomy to physiology or from 
description to mechanism means moving from cell type to cell 
function. This will require integrating transcriptional data with 
other cellular measurements. In this regard, progress has been 
made in obtaining transcriptomic and genomic information (Dey 
et  al., 2015; Macaulay, 2015), transcriptomic and epigenomic 
information (Angermueller et al., 2016), or transcriptomic and 
proteomic information (Darmanis et al., 2016; Frei et al., 2016) 
from the same single cell.
Moving from cell type to cell function will also require under-
standing how single-cell profiles change in response to perturba-
tions. It is important to examine these effects at the single-cell level 
because cell-to-cell heterogeneity has been observed in a diverse 
set of circumstances, such as the response of macrophages to 
bacterial invasion (Avraham et al., 2015), the response of hemat-
opoietic cells to various drugs (Bendall et  al., 2011), and drug 
resistance in adenocarcinoma cells (Kim et al., 2015). Progress in 
the long-term culture of circulating tumor cells (Gao et al., 2014; 
Yu et  al., 2014; Cayrefourcq et  al., 2015; Alix-Panabières et  al., 
2016) enables single-cell functional studies on this important 
class of cells, which should lead to improved cancer diagnosis 
and therapy. Performing perturbation experiments on single cells 
requires care in maintaining the appropriate microenvironment. 
Examining the effects of serum on mouse embryonic stem cells 
(ESCs), researchers (Guo et  al., 2016) concluded that “a large 
proportion of intracellular network variability is due to the extra-
cellular culture environment.” Microfluidic-based approaches 
are attractive for the precise control of the microenvironment 
because they enable structures at a size appropriate for single 
cells. Microfluidic systems for high-throughput preparation of 
sequencing libraries, though, have cell lysis as the initial step and 
thus are not suitable to maintain single cells for experimentation. 
What is required is a system specifically designed to capture, 
maintain, perturb, and observe single cells and then prepare these 
cells for high-dimensional analysis.
In this paper, we report development of an integrated fluidic 
circuit (IFC) that uses fluidic logic to actively select and seques-
ter desired single cells based on particular biological markers of 
interest. This Polaris™ IFC can sequester up to 48 single cells. 
If required, the cells can be cultured in appropriate medium in 
order to control and manipulate the microenvironment around 
the sequestered cells. For adherent cells, appropriate extracel-
lular matrix (ECM) can be coated inside the culture chambers. 
The single cells can be perturbed with a drug or other stimuli 
(i.e., mRNA, cytokines, bacteria, or viruses), with the response 
to perturbation monitored and measured by fluorescence 
imaging. Subsequently, the single cells are processed for cell 
lysis, reverse transcription (RT), and full-length transcriptome 
amplification using template-switching chemistry. Following 
harvest from the IFC, sequencing libraries are generated using 
a modified Nextera® protocol and sequenced on any Illumina® 
platform (Figure 1).
FIgURe 2 | (A) Polaris mRNA-seq dosing integrated fluidic circuit (IFC). The 
polydimethylsiloxane (PDMS) elastomer is attached to a plastic carrier. In 
order to image the cells with low-fluorescence background on the Polaris 
system, the PDMS is backed with a black material. This black backing is 
removed after cell perturbation and fluorescence response measurement. 
Removal of black backing enables high-resolution imaging of cells on a 
fluorescent microscope. The CAD drawing of the microfluidic components is 
shown on the right. The green channels are the control lines. (B) Polaris IFC 
uses fluidic processor to receive serial control inputs and converts them to 
parallel shift register elements. Traditional microfluidic control elements use 
one external control for every internal control.
3
Ramalingam et al. Fluidic Logic for Single-Cell Experimentation
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org September 2016 | Volume 4 | Article 70
MATeRIAlS AnD MeThoDS
Design and Fabrication of logic-Based 
Integrated Fluidic circuit
The nanoscale IFC consists of a plastic carrier and a polydi-
methylsiloxane (PDMS) core (Figure 2A) or fluidic circuit. The 
carrier contains reservoir wells for input and output of reagents 
and circuit control. It provides a platform to facilitate interfac-
ing with the fluidic circuit. The fluidic circuit with the desired 
microfluidic control components was fabricated using multilayer 
soft lithography (MSL®) process (Unger et  al., 2000). Fluidic 
circuit components include flow and control channels, valves, 
multiplexors, and logic devices [such as serial-to-parallel shift 
register (SR)]. Fabrication and operational details of the fluidic 
logic circuits and devices were reported earlier (Devaraju and 
Unger, 2012). The IFC is designed to have the capability to actively 
select single cells based on fluorescent markers, isolate them to 
a desired holding location (cell capture site), apply individual 
conditions (feed medium and dose reagents to cells), and finally 
study the functional response. Execution of all these complex 
functions in a routine fashion requires flexible, programmable 
operational control, which in turn requires many controls in 
a parallel manner. Traditionally, in microfluidics, a dedicated 
external control line is required to independently control a set 
of valves. This imposes a limitation on the number of practical 
on-chip control operations and poses a challenge for scalability by 
requiring more external hardware. On-chip control architecture 
capable of receiving and processing data by elementary compu-
tation and decision-making can integrate programmability of 
controls on-chip and allows an increase in the number of on-chip 
control lines for the same number of external chip connections 
(Figure 2B). We developed such a microfluidic fluidic logic and 
implemented it on our Polaris IFC.
The state-based microfluidic fluidic logic devices and circuits 
utilize static gain and normally closed valves (NCVs). NCVs are 
fabricated by filling specialized control channels with a flash cur-
able prepolymer and curing while the valve is closed. The resulting 
closed valve exerts certain force against fluidic pressure to keep 
the valve closed. The valves are characterized by breakthrough 
pressure: the threshold pressure in the flow channel required 
to push open the valve and restore the continuity of the flow. 
Breakthrough pressure for an NCV can be tailored by controlling 
the pressure at which they are cured. Using these NCVs, we have 
developed static gain valves (SGV) that have the ability to control 
higher (or equal) fluidic pressure using a lower pressure. This 
type of valve is essential to create any logic/feedback structures 
(to account for signal strength losses), which can receive the 
output of the previous element/gate and use it as an input for 
decision making.
Utilizing the SGV, we next built an inverter (NOT gate), which 
was further used to build more complex circuits including bi-
stable flip flops, clocked flip flops (latches), delay flip flops (D-FF, 
one bit of the SR), and complex microprocessors (SR). A SR that 
is capable of processing n + 1 bits of data is formed by combining 
n D flip flops (bits of SR). The SR presented here uses air as the 
medium and receives three active high-pressure inputs: source, 
clock, and data (Figure 3). The pneumatic output of the SR cannot 
be used to control the flow of liquids in microchannels directly, 
due to risk of introducing bubbles. In order to address this issue, 
the signal medium is converted from air to liquid using an inverter.
The Polaris IFC microprocessor receives 28 external signals 
serially and processes them into 28 parallel independent controls 
capable of controlling individual valves or a set of valves. Five 
dedicated high-pressure external active signals are required for a 
SR. The CAD drawing of the various microfluidic components on 
a Polaris IFC is shown in Figure 3. The IFC can accept up to 20 
independent reagents. The fluorescently labeled cells are loaded 
in a serpentine partition channel. Based on a desired combina-
tion of up to three fluorescent markers (refer to Section “Polaris 
Instrument Design” for excitation and emission details), single 
cells are selected and sequentially isolated to the cell capture sites 
through a multiplexer. Up to 48 single cells can be sequestered 
on a single Polaris IFC. Subsequently, these 48 cells are processed 
through template-switching chemistry for full-length cDNA 
generation for mRNA-seq. In brief, the cells are lysed and reverse-
transcribed, and full-length cDNA is preamplified by long and 
accurate PCR.
polaris Instrument Design
The Fluidigm Polaris system (Figure 4A) consists of four major 
modules: (1) thermal control module; (2) imaging module; 
(3) pneumatic control module; and (4) environmental control 
FIgURe 3 | cAD drawing of microfluidic control components on polaris mRnA-seq dosing IFc (A). The shift register (B) enables active selection of single 
cells. The dilute single-cell suspension is loaded into a serpentine partition channel (D). The cell suspension liquid flow is stopped, and the partition channel is 
imaged to identify single cells based on a particular set of fluorescence markers. The selected cells are then microfluidically moved downstream to a cell capture site 
(F) through a multiplexer (e). The IFC is capable of accepting 20 reagents (g) as input. The shift register uses inverter (c) and a set of source, clock, and data (h).
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(EC) module. The thermal module consists of a Peltier-based 
thermoelectric couple (TEC) device for heating/cooling. The 
TEC module can provide temperature in the range of 4–99°C. 
Vacuum grooves on the thermal module are designed to enable 
tight contact with the glass-based integrated heat spreader (IHS) 
on the Polaris IFC. This ensures thermal uniformity across the 
fluidic circuit. The imaging module contains a five-color LED 
light engine for excitation (Ex wavelengths: 438, 475, 530, 575, 
FIgURe 4 | (A) Components of Polaris instrument. The instrument consist of four major modules: (1) thermal module, enables preparative chemistry on sequestered 
single cells; (2) imaging module, consists of LED excitation and emission collection by a camera; (3) pneumatic module, controls the movement of reagents inside 
microfluidic channel by application of positive pressure on the IFC carrier; and (4) environmental control module, maintains the temperature, humidity, and blood gas 
flow rate for single-cell culture on-IFC. (B) Components of environmental control interface plate. The top of the interface plate contains glass coated with indium tin 
oxide. Internal heaters are used to maintain the temperature of the closed chamber between the interface plate and Polaris IFC. The temperature and relative 
humidity inside the closed chamber (after clamping with Polaris IFC) are measured by T/RH sensor. Blood or premixed gas required for cell culture is pumped 
through mixed gas inlet port on the interface plate. Polaris IFC is shown for reference.
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TABle 1 | Recommended stains and corresponding excitation and 
emission filter on polaris system.
channel 
name
excitationa emission Recommended stains
FAM™ 475/40 525/25 Alexa Fluor 488 (selection marker)
VIC® 530/20 570/30 CellTracker Orange CMRA Dye 
(universal marker)
Cy5® 632/28 700/30 Alexa Fluor 647 (selection marker)
aExcitation values are center wavelength/band pass (≥90%).
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and 632 nm). The light source from the engine is collected and 
projected onto the fluidic circuit using fiber optics. The emitted 
signal from the fluidic circuit passes through an emission filter 
(five Em wavelengths: 488, 525, 570, 630, and 700  nm) and is 
collected by CCD camera with 6-μm pixel resolution through a 
custom-designed collimator lens.
The pneumatic control module generates and stores air with 
volume up to 1 L. The system can achieve a maximum pressure of 
100 psi. The pneumatic controller generates a vacuum on the ther-
mal chuck, clamps the Polaris IFC against the EC interface plate 
(IP) to enable a closed environment around the IFC, and loads 
reagents from the inlets on the IFC carrier to the microchannels 
and reagent chambers of the fluidic circuit. The system contains 
segregated zones to regulate four different pressures simultane-
ously. The EC module provides an environment suitable for 
cell culture using user-desired gas composition. Environmental 
parameters such as temperature, relative humidity (RH), and 
mix gas flow rate across the fluidic circuit are monitored and 
controlled. The gas inside the closed chamber is heated by two 
heater coils. The gas inlet on the EC IP is used to regulate the flow 
of gas across the fluidic circuit. The EC IP (Figure 4B) contains an 
indium tin oxide (ITO) coated glass on the top to maintain ther-
mal control in the EC while allowing imaging through the EC IP. 
During cell culture operation, the ITO glass is heated to prevent 
condensation. During cell culture, the environment around the 
fluidic circuit is maintained by blood gas (5% CO2, 5% oxygen, 
and 90% nitrogen) or premixed gas of choice (for example, 5% 
CO2, 20% oxygen, and 75% nitrogen). Before on-IFC cell culture, 
a rectangular sponge saturated with water is installed inside the 
closed chamber to provide the desired humidity through heating. 
The EC IP is equipped with two sensors (T/RH) to measure and 
maintain temperature at 37°C and RH at 90%.
K562 cell culture and cD59 Staining
K562 cells (ATCC® CCL-243) are cultured in T25 flasks in a vol-
ume ranging from 10 to 15 mL in an incubator (37°C, 5% CO2). 
The culture medium contains IMDM + GlutaMAX™-I + 25 mM 
HEPES + 3.024 g/L sodium bicarbonate (Gibco, 31980-030) and 
is supplemented with 10% FBS. The cells were fed every 2–3 days 
by dilution to 200,000 cells/mL. The K562 cells were stained 
with CellTracker™ Orange (CTO) CMRA Dye (Thermo Fisher 
Scientific, C34551) as universal marker and Alexa Fluor® 647 
conjugated CD59 antibody. The recommended dyes and cor-
responding excitation and emission filters on the Polaris system 
are shown in Table 1. Immediately before use, the cell staining 
solution was prepared by adding 0.6 μL of 1 mM CTO to 2 mL of 
HBSS without calcium or magnesium (−/−) at a final concentra-
tion of 0.3 μM. The cell staining solution was protected from light 
until use within 30 min. A total of ~1.5 × 106 cells was aliquoted 
in a 15 mL non-pyrogenic conical tube. The cell suspension was 
centrifuged at 300 × g for 3 min. Following this, the medium was 
aspirated without disturbing the pellet, and 2 mL of cell staining 
solution was added to the pellet and gently suspended by pipet-
ting up and down three times. The cells were then incubated in 
the dark at 37°C for 20 min with occasional inverting and flicking. 
Following this, the cells were washed by adding 12 mL of HBSS 
to the cells in the 2 mL of staining buffer and then centrifuged 
at 300 × g for 5 min. Supernatant was aspirated and discarded 
without disturbing the pellet. The pellet was then resuspended 
in 200  μL of HBSS. The CTO-stained K562 cells were split 
into two tubes of 100 μL each. One tube was used as negative 
surface-stained cell population, and the other tube was processed 
further to stain CD59 epitope. In order to stain the surface CD59 
epitope, 10 μL of CD59 biotinylated antibody (BD Biosciences, 
555762, 100 tests, 2.0 mL) was added to 100 μL of CTO-stained 
cells. For negative surface-stained cell control, 10 μL of HBSS 
was added. Both the tubes were incubated at room temperature 
for 20 min with occasional inverting and flicking. Subsequently, 
13 mL of HBSS was added to each tube and centrifuged at 300 × g 
for 5  min. The pellet was resuspended in 100 μL of HBSS. To 
this, 0.5  μL of Streptavidin Alexa Fluor® 647 (Thermo Fisher 
Scientific, S32357, 2 mg/mL stock) was added to positive-stain 
tube with CD59 biotinylated antibody in 100-μL cell suspension. 
This solution was mixed gently by pipetting up and down five 
times. Following this, the stain solution was incubated at room 
temperature for 15 min with occasional flicking. Again, 13 mL 
of HBSS was added to each tube, mixed by gently pipetting up 
and down, and centrifuged at 300 × g for 5 min. The supernatant 
was removed, and the pellet was resuspended in ~100–150 μL 
culture medium with FBS, but without phenol red, to prevent 
high background fluorescence during cell selection on the Polaris 
system. The resuspension volume of culture medium accounts for 
cell losses during the staining procedure and was chosen to yield 
a cell concentration greater than the target concentration of 550 
cells/μL. Typically, 10 μL of cell mix is loaded into a C-Chip™ 
Disposable Hemocytometer (INCYTO, DHC-N01) and imaged 
on the Polaris system to estimate the staining intensity and 
purity. In order to achieve optimal buoyancy, cells in the range of 
333–550 cells/μL are mixed with suspension reagent (Fluidigm, 
101-0434). Typically, the ratio of cells to cell suspension reagent 
is 3:2. However, this ratio might need optimization depending on 
the cell type.
IFc operation
The Polaris IFC is first primed to fill the control lines on the 
fluidic circuit, load cell capture beads, and the inside of PDMS 
channels is blocked to prevent non-specific absorption/adsorp-
tion of proteins. In order to capture and maintain the single 
cells in the sites, the capture sites (48 sites) are preloaded with 
beads that are linked on-IFC to fabricate a tightly packed bead 
column during the IFC prime step. In the case of adherent cells, 
ECM is coated inside the cell capture chambers during prime 
FIgURe 5 | (A) Cells in suspension are loaded into a serpentine partition 
channel (CAD design image). (B) Image analysis shows movement of 
fluorescent cells inside the serpentine channel during reagent flow. Once  
the reagent flow is stopped, single cells are separated from each other.  
The system software identifies single cells based on desired fluorescent 
markers. (c) After identification, single cells are isolated by moving them  
to the capture sites through a fluidic multiplexer. (D) Image of cultured BJ 
fibroblast cells. The Polaris IFC can be imaged on a microscope to obtain 
high-resolution micrographs.
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the cells are imaged in the partition channel for different fluo-
rescent markers, as selected by the user. Based on automated 
image analyses by the system’s software, only single cells with 
the desired combination of fluorescent markers are selected 
and isolated to the cell capture site. Any doublets or single cells 
with undesired fluorescent combinations are not selected by the 
software for further experimentation (Figure 5B). The selected 
single cells are moved to capture sites through a multiplexer 
(Figure 5C). The system takes images of the capture sites to con-
firm the arrival of single cells from a particular position in the 
partition to a particular capture site number. Figure 5C shows 
a typical image from the Polaris system showing K562 single 
cells captured inside sites packed with a column of beads. The 
system will then select and isolate all available single cells from 
a partition fill as per desired fluorescent marker combination. 
Once it completes selection of candidate cells, the system refills 
the serpentine partition to look for more candidate single cells. 
The system repeats this process to select and isolate single cells 
until it fills all 48 capture sites.
If desired, the single cells can then be cultured in the 
capture sites. It is possible to culture either suspension (e.g., 
K562) or adherent (e.g., BJ fibroblast) cells. For adherent cells, 
extracellular matrix can be coated inside the capture site dur-
ing the IFC priming step. Figure 5D shows a Polaris image of 
a cultured BJ fibroblast (adhered). Based on the experimental 
design, it is possible to dose these single cells and on-IFC-
cultured single cells with drugs or other cell stimuli. Finally, 
the single cells are processed through template-switching 
mRNA-seq chemistry for full-length cDNA generation and 
preamplification on-IFC.
Full-length cDnA generation
Preamplified full-length cDNA of selected single cells are 
generated on-IFC, and the amplicons are harvested through 
48 different outlets. We used the SMARTer Ultra® Low RNA 
Kit for Illumina Sequencing (Clontech®, 634936) to generate 
preamplified cDNA. The selected and sequestered single cells 
were lysed using Polaris cell lysis mixture. The 28-μL cell lysis 
mix consists of 8.0  μL of Polaris Lysis Reagent (Fluidigm, 
101-1637), 9.6  μL of Polaris Lysis Plus Reagent (Fluidigm, 
101-1635), 9.0 μL of 3′ SMART™ CDS Primer II A (12 μM, 
Clontech, 634936), and 1.4  μL of Loading Reagent (20X, 
Fluidigm, 101-1004). Synthetic RNA spikes can be optionally 
used with cell lysis mix. We typically use ArrayControl™ 
RNA spikes 1, 4, and 7 (Thermo Fisher Scientific, AM1780) to 
establish the functionality of RT and PCR on-IFC. We also use 
ERCC spikes at 1:50,000 dilution (final in lysis mix) for effi-
ciency and quantification estimations. In order to implement 
synthetic RNA spikes, we thoroughly mix 96.5 μL of loading 
reagent with 2.5 μL of SMARTer Kit RNase Inhibitor (40 U/μL; 
Clontech, 634936) and subsequently add 1 μL of synthetic RNA 
spike to this spike mix. If RNA spike is used, then 1.4 μL of the 
loading reagent is replaced with the spike mix. The thermal 
profile for single-cell lysis is 37°C for 5 min, 72°C for 3 min, 
25°C for 1 min, and hold at 4°C.
The 48-μL preparation volume for RT contains 1X SMARTer 
Kit 5X First-Strand Buffer (5X; Clontech, 634936), 2.5-mM 
step. After completion of the prime step, the cell mix (cells with 
suspension reagent) is loaded on the Polaris IFC and single 
CTO+/CD59+ cells are selected to capture sites. We extensively 
tested the performance of the Polaris IFC and system at three 
different cell purities (3, 10, and 50%). The cell purity is defined 
as the ratio of CTO+/CD59+ cells to CTO+/CD59− cells. During 
the cell selection step, the suspended cells are loaded into the 
serpentine partition channel (Figure  3). Subsequently, the 
flow inside the partition channel is stopped (Figure  5A), and 
FIgURe 6 | Total-RnA-based performance test (two-step) workflow and pipetting map. (A) Workflow to prime Polaris IFC with beads, back-load them with 
RNAspikes 147, simulate front dosing with diluted ERCC spikes, and generate cDNA using mRNA-seq chemistry. The cDNA amplicons from Polaris IFC were 
analyzed on the Fluidigm M96.96 IFC using 85 qPCR assays for specific genes, 8 assays for ERCC RNA spikes, and 3 assays for RNAspikes 147. (B) Pipetting 
map for IFC prime step. During prime step, RNAspikes 147 are back-loaded to 8 specific inlets with cell capture beads. (c) Pipetting map for front-dosing simulation 
with ERCC RNA spikes, followed by mRNA-seq chemistry.
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SMARTer Kit Dithiothreitol (100 mM; Clontech, 634936), 1-mM 
SMARTer Kit dNTP Mix (10  mM each; Clontech, 634936), 
1.2-μM SMARTer Kit SMARTer II A Oligonucleotide (12 μM; 
Clontech, 634936), 1-U/μL SMARTer Kit RNase Inhibitor 
(40 U/μL; Clontech, 634936), 10-U/μL SMARTScribe™ Reverse 
Transcriptase (100 U/μL; Clontech, 634936), and 3.2 μL of Polaris 
RT Plus Reagent (Fluidigm, 101-1366). All the concentrations 
correspond to those found in the RT chambers inside the Polaris 
IFC. The thermal protocol for RT is 42°C for 90 min (RT), 70°C 
for 10 min (enzyme inactivation), and a final hold at 4°C.
FIgURe 7 | (A) Front-dosing strategy. The capture sites on Polaris IFC are segregated as six groups of eight sites. ERCC spike-in mix is loaded into the second 
capture site of every group (Group alt 2). For negative control, 1X Preloading Reagent was loaded into Group alt 4, 6, and 8. (B) Sequential chambers for multistep 
chemistry. The capture site with beads holds 2 nL of liquid. The lysis mix is loaded into chamber 1 (9 nL), then reverse transcription mix is loaded into chambers 2 
and 3 (9 nL each), and PCR mix is loaded into chambers 4 and 5 (135 nL each). (c) Chemistry loading sequence and its function.
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The 90-μL preparation volume for PCR contains 1X 
Advantage 2 PCR Buffer [not short amplicon (SA)] (10X, 
Clontech, 639206, Advantage® 2 PCR Kit), 0.4-mM dNTP 
Mix (50X/10 mM, Clontech, 639206), 0.48-μM IS PCR Primer 
(12 μM, Clontech, 639206), 2X Advantage 2 Polymerase Mix 
(50X, Clontech, 639206), and 1X Loading Reagent (20X, 
Fluidigm, 101-1004). All the concentrations correspond to 
those found in the PCR chambers inside the Polaris IFC. The 
thermal protocol for preamplification consists of 95°C for 
1 min (enzyme activation), five cycles (95°C for 20 s, 58°C for 
4 min, and 68°C for 6 min), nine cycles (95°C for 20  s, 64°C 
for 30 s, and 68°C for 6 min), seven cycles (95°C for 30 s, 64°C 
for 30 s, and 68°C for 7 min), and final extension at 72°C for 
10 min. The preamplified cDNAs are harvested into 48 separate 
outlets on the Polaris IFC carrier.
qpcR Analysis on Biomark™
Harvested samples from Polaris IFCs were analyzed by qPCR 
using 96.96 Dynamic Array™ IFCs and the Biomark™ HD 
system from Fluidigm. Processing of the IFCs and operation of 
the instruments were performed according to the manufacturer’s 
procedures. For detection using the RNA expression and splice 
variant assays, a Master Mix was prepared consisting of 360-μL 
SsoFast™ EvaGreen® Supermix with Low ROX (BioRad 172-
5211) and 36-μL 20 × DNA Binding Dye Sample Loading Reagent 
(Fluidigm 100-5360), and 3.3 μL of this mix was dispensed to 
10
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each well of a 96-well assay plate. Diluted harvest product (2.7 μL) 
was added to each well, and the plate was briefly vortexed and 
centrifuged. Following priming of the IFC in the IFC Controller 
HX, 5 μL of the sample + Master Mix were dispensed to each 
sample inlet of the 96.96 IFC. Five microliters of each 10 × assay 
[5 μM each primer, 1 × assay Loading Reagent (Fluidigm 100-
5359)] were dispensed to each Detector Inlet of the 96.96 IFC. 
After loading the assays and samples into the IFC in the IFC 
Controller HX, the IFC was transferred to the Biomark HD, and 
PCR was performed using the thermal protocol GE Fast 96 × 96 
PCR +  Melt v2.pcl. This protocol consists of a thermal mix of 
70°C, 40  min; 60°C, 30  s, hot start at 95°C, 1  min, PCR cycle 
of 30 cycles of 96°C, 5 s; 60°C, 20 s, and melting using a ramp 
from 60 to 95°C at 1°C/3 s. Data were analyzed using Fluidigm 
Real-Time PCR Analysis software using the Linear (Derivative) 
Baseline Correction Method and the Auto (Global) Ct Threshold 
Method. The data are exported as a.csv file into an Excel® macro 
to compile and compare the data against in-house specifications.
ReSUlTS
performance evaluation of polaris IFc
In order to statistically evaluate the performance of the 
Polaris IFC, we designed and developed two performance 
tests: (1) total-RNA-based performance test (RNA PT) and 
(2) single-cell-based key performance test (KPT). Since single 
cells are heterogeneous, it would be difficult to evaluate the 
performance uniformity across 48 capture sites using a cell-
based test method. Hence, we developed a 20-cell-equivalent 
total-RNA PT to evaluate and improve the performance of the 
Polaris IFC during the initial phase of the IFC development 
process.
Total RNA-Based Performance Test
The primary objective of this test is to statistically validate a 
workflow that is very close to the cell-based experiments on the 
Polaris system and yet collects critical information about uni-
formity of cDNA synthesis across IFC, reaction line cross-talk 
(on-IFC), and IFC-to-IFC correlation. To achieve this objective, 
we simulated steps such as loading of cell capture beads and the 
thermal step for cell lysis in the total-RNA PT. The workflow of 
the total-RNA PT is shown in Figure 6A. Briefly, the RNA-PT 
is a two-step procedure. In the first step, the control lines on the 
Polaris IFC are primed, channels are blocked, and cell capture 
beads are back-loaded with ArrayControl RNA SPIKES (1, 
4, and 7 only, Thermo Fisher Scientific, AM1780; henceforth 
referred to as RNAspikes 147) in eight specific capture sites 
(Figure 6B).
The ArrayControl RNA Spikes are used to evaluate the back-
dosing cross-talk using highly sensitive qPCR assay designed to 
detect RNA spikes 1, 4, and 7 (three total ArrayControl RNA 
Spikes). After the priming step, six specific capture sites are 
loaded with ERCC RNA Spike-In Mix (Thermo Fisher Scientific, 
4456740) to estimate the cross-talk for front-loaded reagents and 
dosing agents. Although the ERCC RNA mix contains 92 spike-
ins, only 8 ERCC spike-ins were probed using qPCR assays. The 
front-dosing strategy is illustrated in Figure 7A and the pipetting 
map is shown in  Figure 6C.
For negative control, 1X Preloading Reagent (Fluidigm, 100-
9942) was loaded into specific inlets and capture sites (Figure 7C). 
After completion of front dosing, the mRNA-seq chemistry 
prep is integrated with the dosing step. The lysis mixture for the 
RNA-PT contains Leukemia (K562) Total RNA (Thermo Fisher 
Scientific, AM7832) at a concentration equivalent to 20 cells of 
total RNA in every cell capture site (48 sites). The cell capture site 
is serially connected to five chambers to enable multistep reac-
tion chemistry (Figure 7B). Cell lysis mixture is loaded into the 
first 9-nL chamber. Then, RT mixture is loaded in 18-nL volume 
(two 9-nL chambers). Finally, PCR mixture for preamplification 
of full-length cDNA is loaded in 270-nL volume (two 135-nL 
chambers).
The preamplified cDNA is harvested in ~7 μL volume. The 
harvest is further diluted by addition of 10 μL of DNA Dilution 
RGT (Fluidigm, 100-9167). In order to evaluate IFC uniformity 
and other performance metrics, we designed 88 Delta Gene™ 
assays (Fluidigm) for K562 (85 genes covering high and low 
expressors) and RNAspikes 147. In addition to these 88 assays, we 
used 8 ERCC qPCR assays from a published work (Devonshire 
et al., 2011). In total, we used 96 intercalating dye-based qPCR 
assays for read-out of RNA PT on an M96.96 Dynamic Array™ 
IFC (Fluidigm). We routinely test positive and negative tube 
controls for every chemistry preparation by qPCR assays on 
the M96.96. In order to do this, 2 out of the 48 samples from a 
Polaris IFC are replaced by positive and negative tube controls 
on M96.96. The positive tube control contains total RNA from 
K562, RNAspikes 147, and ERCC. The tube controls are used 
to validate the functionality of chemistry preparation on a 
particular day. Harvest products from two Polaris IFC are tested 
on a single M96.96 Dynamic Array IFC run. A typical qPCR Ct 
heat map and associated Excel macro for two Polaris RNA PTs 
are shown in Figures 8A,B. In order to statistically validate the 
performance, we tested 44 Polaris IFCs with RNA PTs. IFC and 
reagents from minimum of three manufacturing lots were used. 
Tolerance limit or interval analyses were performed on more 
than 40 Polaris IFC runs. The distribution of data and tolerance 
limit analyses for different metrics for the RNA PTs are shown 
in Figure 9.
Single-Cell-Based Key Performance Test
Key performance test was developed and validated using one 
cell type each for suspension (K562) and adherent (BJ fibro-
blast) cells. As described in Section “Materials and Methods,” 
cells are stained with the universal fluorescent marker, CTO. 
A subset of these cells were stained for surface marker using 
antibody conjugated with Alexa 647. In the case of K562, we 
used Anti-Human CD59-Biotin (BD Biosciences, 555762) 
with Streptavidin Alexa 647, and for BJ fibroblast, we used 
Anti-Mouse/Human CD44-Alexa 647 (BioLegend 103018). 
The double-stained cells (universal CTO and surface marker 
Alexa 647) were mixed with cells stained with CTO only to 
achieve three different purity percentages (3, 10, and 50%). The 
cells were selected for universal CTO and surface marker. For 
BJ fibroblasts, we tested two different workflows, one with cell 
FIgURe 8 | (A) Typical heat map of high-throughput qPCR assay for RNA-based performance test. The M96.96 IFC (96 samples) can accept amplicons from two 
Polaris IFCs (48 samples each). For every Polaris IFC, we replace two samples with positive and negative control samples. The columns are assays (85 high- and 
low-expressing assays; 8 ERCC spike assays; and 3 RNAspike 147 assays). The rows are diluted amplicons from Polaris IFCs. (B) Excel macro for the RNA-based 
performance test.
11
Ramalingam et al. Fluidic Logic for Single-Cell Experimentation
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org September 2016 | Volume 4 | Article 70
FIgURe 9 | Tolerance limit analyses from 44 polaris IFc runs using RnA-based performance test. n is the sample number after removal of outliers. 
Outliers are estimated by Tukey’s box plot. The percentage of outliers removed ranged from 0 to 5%. (A) Average assay SD. The data fit a normal distribution  
with goodness of fit P-value of 0.2813. The upper tolerance interval for this metric is 0.395. (B) Distribution of drop outs for high-expressing assays only.  
(c) Distribution of drop outs for both high and low expressors. (D) Back-loaded dosing cross-talk. (e) Distribution of slope for IFC-to-IFC correlation. The data fit a 
normal distribution with tolerance interval of 1–1.08. (F) Distribution of R2 for IFC-to-IFC correlation. The data fit a normal distribution with lower tolerance limit of 
0.959.
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selection followed by chemistry (immediate) and another to 
dose the BJ fibroblasts with medium every 4 h for 24-h adherent 
culture, followed by chemistry (BJ dosing). In order to evaluate 
the cell viability prior to the cell lysis step, we used Zombie 
Yellow™ cell viability stain (BioLegend, 423103; λex = 396 nm 
and λem = 572 nm), which stains dead cells. Performance metrics, 
such as number of sites occupied with single cells out of the total 
48 sites (cell selection), number of cells retained after dosing 
and prior to cell lysis (cell retention), and number of viable cells 
prior to lysis, were evaluated. On average from 20 Polaris IFC 
runs, our cell selection was ~95% for K562 and BJ fibroblast with 
different purity percentages (Figure  10A). For cell retention, 
FIgURe 10 | Single-cell selection, retention, and viability performance 
using single-cell key performance test. (A) Percentage of single cells 
selected (out of 48 total capture sites) for K562 (suspension) and BJ 
fibroblast (adherent) at different cell purity concentrations (3, 10, and 50%). n 
is number of Polaris IFCs tested. (B) Single cells retained after dosing and 
culture. Cells are imaged and counted before the cell lysis step. K562 and BJ 
fibroblasts were selected and immediately processed for mRNA-seq 
chemistry preparation. BJ fibroblasts were also selected, cultured, and dosed 
with cell culture medium for 24 h (BJ dosing). Data from three IFCs are 
presented here. (c) Single-cell viability as assessed by Zombie stain on-IFC.
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>47/48 sites showed presence of single cells as enumerated after 
the cell selection step and prior to cell lysis step (Figure 10B). 
The average cell viability was ~90% as estimated from 20 Polaris 
IFC runs (Figure 10C).
The Polaris system generates very high quality (size distribu-
tion) and quantity (yield) of preamplified cDNA from single 
cells. The size distribution of preamplified cDNA from single 
cells, as evaluated using Bioanalyzer 2100 and the DNA high-
sensitivity chip (Agilent), is typically in the size range of 0.3–7 kb 
(Figure  11A). For yield, preamplified cDNA from single cells 
was quantified using PicoGreen-based dsDNA quantification 
assay (Quant-iT™ PicoGreen® dsDNA Assay Kit, Thermo Fisher 
Scientific, P7589). The average total cDNA yield per single K562 
cell is 38.42 ± 8.08 ng (Figure 11B). We randomly selected ~14 
single cells from three Polaris IFC runs, barcoded them using 
modified Nextera library prep, and pooled them to generate a 
single sequencing library. A representative library profile from 
42 single cells is shown in Figure  11C. The majority of the 
single-cell library falls in the range of 200–2,000  bp. For three 
sequencing libraries from nine Polaris IFCs tested with K562 
immediate chemistry, sequencing data from three MiSeq™ runs 
using v2 150 bp PE kit were compiled, and tolerance limits (90% 
confidence with 95% population coverage) were estimated for 
two key sequencing metrics (Figure 12). The average percentage 
of reads mapping to rRNA/total reads is 0.122%. The Box–Cox 
transformed data fit a normal distribution with a Shapiro–Wilk 
P-value of 0.0983. Based on the normal distribution, the upper 
tolerance limit for percentage of reads mapping to rRNA is 0.3% 
(Figure 12A). The mean number of genes detected is 6,967 ± 115. 
The data fit a normal distribution with a lower tolerance limit 
of 5,919 genes as estimated from 115 single-cell datapoints 
(Figure 12B).
We extensively analyzed our single-cell sequencing data 
for transcript coverage bias and possible positional bias of 
single cells selected across 48 capture sites on the Polaris IFC 
(Figure  13). We noted uniform coverage along the transcript 
length (Figure 13B) without any positional bias on the Polaris 
IFC. The plot of normalized coverage vs. normalized distance 
along the transcript with respect to capture sites (2, 3, 4 and 40, 
41, 42) from a Polaris IFC is shown in Figure  13B. A plot of 
median 3′ end bias of transcript coverage with respect to capture 
site number indicates no positional bias across three Polaris IFC 
runs (Figure 13A). In order to understand if there is any pos-
sible effect of hypoxia on single cells due to spatial location of 
capture sites on the Polaris IFC, we analyzed the expression value 
of HIF1A gene across different capture sites. Up-regulation of 
hypoxia-induced factor 1 gene (HIF1A) is a known consequence 
of hypoxia (Choudhry and Mole, 2015). Expression analyses of 
HIF1A did not show any positional bias with respect to the cap-
ture sites (Figure 13C). It should be noted that we recommend 
strictly following the Polaris workflow as described in the Polaris 
protocol document (Fluidigm, 101-0082). Any deviation from 
the validated workflow might lead to introduction of possible 
bias at multiple levels.
Sensitivity Studies Using eRcc Spike-Ins
An alternative way to evaluate performance of single-cell mRNA-
seq on the Polaris system is to implement use of the ERCC RNA 
Spike-In Mix 1 in the lysis mix. The ERCC control mix consists 
of 92 polyadenylated transcripts with a size range of 273–2,022 
bases and six orders of magnitude range in concentration. We 
tested both qPCR- and sequencing-based methods for detec-
tion of ERCC spikes. Ninety-two primer pairs were designed 
FIgURe 11 | (A) Typical cDNA distribution from single cells from three different Polaris IFC runs (A1–A3). The peak for RNAspikes 147 is around 1,000 bp. 
(B) Distribution of cDNA yield from 358 single K562 cells from multiple Polaris IFC runs. The average cDNA yield per cell is 38.42 ng with a SD of 8.08 ng. 
(c) Library profile of 42 single cells.
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to target the corresponding transcripts for qPCR testing. qPCR 
was performed on a Fluidigm 96.96 Dynamic Array IFC. 
Stochastic distribution of transcripts was observed when the 
input concentration was 25 copies per reaction or less on the 
Polaris IFC followed by qPCR detection on the 96.96 Dynamic 
Array (Figure 14A). Single-copy RNA detection is demonstrated, 
although intermittently, likely due to sampling at the reaction site. 
Transcripts at 1.6 copies per reaction were intermittently detected 
by qPCR on the 96.96 Dynamic Array IFC. We also evaluated 
the detection rate of ERCC spikes (>1.6 copies/reaction) using 
an approach based on massive parallel sequencing. There were 7 
ERCC spikes (ERCC-00170; ERCC-00148; ERCC-00126; ERCC-
00099; ERCC-00054; ERCC-00163; ERCC-00059), which were 
at a concentration of 1.6 copies per Polaris reaction chamber. 
One of the 7 ERCC spikes (ERCC-00054) was not detected in 
any of the 19 single-cell samples. If we remove this datapoint as 
an outlier, the average detection rate of ~1.6 copies is 28%. Based 
on Poisson estimates, single-copy detection rate should be ~33% 
FIgURe 12 | Distribution of sequencing metrics for single cells. (A) Percentage of reads mapped to rRNA/total reads. The average mapping to rRNA is 
0.122% from 116 single-cell sequence datapoints. The upper tolerance limit for percentage rRNA mapping is 0.3%. (B) Number of genes detected (TPM > 1). 
Distribution of genes detected from 115 single-cell sequence data. The average genes detected is 6,967, with a SD of 115. The data fit a normal distribution, with a 
lower tolerance limit of 5,919.
15
Ramalingam et al. Fluidic Logic for Single-Cell Experimentation
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org September 2016 | Volume 4 | Article 70
(67% should be a failure event). The single-copy detection rate 
(28%) from the Polaris system is very close to expected theoreti-
cal estimates based on Poisson statistics (Figure 14B).
Single-cell Transfection of ngFp mRnA 
and gFp expression Analyses
In order to demonstrate dosing and functional response analyses, 
we transfected single K562 cells with nuclear green fluorescent 
protein (nGFP) mRNA and cultured the transfected single K562 
for 16  h. During this culture duration, the cells translated the 
nGFP mRNA and expressed the GFP inside the cell. The imag-
ing capability of Polaris enables monitoring of GFP expression. 
Subsequently, the cells were processed for mRNA-seq chemistry 
on-IFC and sequenced on MiSeq to quantify the reads mapped 
to GFP. K562 cells stained with CTO were selected on Polaris 
IFC. To carry out the single-cell transfection, 10 μL of Stemfect 
RNA transfection reagent was mixed with 240-μL Stemfect 
transfection buffer (Stemgent® Stemfect™ RNA Transfection Kit, 
00-0069) (Mix A). The stock nGFP mRNA (Stemgent, 05-0019) 
at 100 ng/μL was diluted with Stemfect transfection buffer first 
and then further diluted with Mix A to make mRNA transfec-
tion complex. This complex was incubated at room temperature 
for 15 min and further diluted with K562 cell culture medium 
(refer to Section “K562 Cell Culture and CD59 Staining”) to 
achieve different final concentrations (0.5 and 1 ng/μL) of nGFP 
mRNA. Selected single K562 cells were cultured with the nGFP 
mRNA transfection complex with culture medium at 37°C with 
5% CO2 on the Polaris IFC. During this cell culture incubation 
time, images were taken every hour to monitor the onset of GFP 
expression. Image analyses (Figure 15) showed that single cells 
picked up nGFP mRNA at 0.5 and 1 ng/μL concentrations and 
expressed the green fluorescent proteins, thereby reinforcing 
the fact that single cells on Polaris IFC are healthy and are able 
to uptake naked mRNA and translate it to protein capable of 
being transfected. Figure 15A shows typical time-series images, 
which can be obtained from the Polaris system. It should be 
noted that for this particular experiment, the imaging interval 
was set to 1 h, but the Polaris system is capable of taking suc-
cessive images in a rapid mode. We noted onset of GFP gene 
expression around the 3-h time frame at single-cell resolution. 
The cDNA pool showed a length range from 0.3 to 9.2 kb, with an 
average length ~2 kb. It is also noted that >85% of the total cDNA 
pool lies between 0.5 and 9.2 kb (Figure 15B). Sequencing data 
show that the cells transfected with nGFP mRNA harbored the 
FIgURe 13 | Bias vs. capture site number. (A) Median 3′ end bias was analyzed for random single cells picked for sequencing. No 3′ bias was noted for cells 
from three Polaris IFC runs (B) HIF1A gene expression of cells across different capture sites. (c) Sequencing coverage as estimated by Picard for single cells. 
Uniform coverage noted across different capture sites from a Polaris IFC.
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extracellular mRNA even after 16 h of culture. As expected, the 
control cells without nGFP transfection did not show any map-
ping to GFP sequence. The transfection of nGFP did not alter the 
mapping to genome and transcriptome when compared to the 
control cells (Figure 15C). The nGFP-transfected cells showed 
percentage average reads mapping of 0.57, 87.99, and 47.82% to 
GFP, genome, and transcriptome, respectively (n = 7), while the 
control K562 showed percentage average mapping of 0, 88.03, 
and 49.22 (n = 7).
DIScUSSIon
In this work, we report design and development of an inte-
grated system to perform functional studies on single cells. 
FIgURe 14 | (A) Heat map (qPCR assay) for ERCC spike-in with single SKBR3 cells. The columns are 92 qPCR assays designed and developed for ERCC 
spike-in. The rows are amplicons from single SKBR3 cells with ERCC spike-in. The ERCC assays on the columns are sorted by concentrations. (B) Detection rate of 
ERCC spikes with >1.58 copies per Polaris IFC chambers.
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We developed a nanoscale IFC, which employs fluidic logic to 
actively select single cells, and a system capable of performing 
multiple functionalities. The performance of the developed 
IFC and system was extensively tested using RNA-based and 
single-cell-based performance tests. These tests were specifi-
cally designed to evaluate different functionalities of the IFC 
and system. The functional capability of the Polaris IFC and 
system has been successfully demonstrated using transfection 
of naked nGFP mRNA, followed by monitoring of nGFP 
expression and finally analysis of the whole set of mRNA 
transcripts by massive parallel sequencing. It is noted that it is 
not currently possible to perform studies reported in this work 
on any other single-cell platforms. The limitation of the current 
system includes limited number of cells for functional studies 
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(up to 48 cells). However, the requirement on the number of 
cells depends on the biological question, and it is possible to 
expand the capability of the IFC consumable to process more 
cells in the future.
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